Amlodipine vs nifedipine retard. Evaluation of efficacy and tolerability using ambulatory blood pressure monitoring

Clinical Drug Investigation

Volumn 13, Issue SUPPL. 1, 1997, Pages 83-91

  Bossini, Alfredo ^a,d   Di Veroli, Claudio ^a   Germanò, Ugo ^a   Monteverde, Angela ^b   Campanini, Mauro ^b   Airoldi, Gian Luca ^b   Nami, Renato ^c   Panza, Filomena ^c   Pavese, Giovanni ^c   Cagli, Vito ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d POLICLINICO UMBERTO I   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; NIFEDIPINE;

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG TOLERABILITY; ESSENTIAL HYPERTENSION; FEMALE; HEADACHE; HEART PALPITATION; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIDE EFFECT;

EID: 0030854660     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199700131-00015     Document Type: Article

References (15)

1. Burges RA, Dodd MG. Amlodipine. Cardiovasc Drug Rev 1990; 8 (1): 25-44
2. Muller JE, Stone PH, Turi ZG, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985; 313: 1315-22
3. Mulcahy D, Cunningham D, Cream P, et al. Circadian variation of total ischaemic burden and its alteration with antianginal agents. Lancet 1988: 2 (8614): 755-9
4. Taylor CR, Hodge EM, White DA. Circadian rhythm of angina: similarity to circadian rhythms of myocardial infarction, ischaemic ST segment depression, and sudden cardiac death. Am Heart J 1989; 118 (5 Pt 2): 1098-9
5. Myers A, Dewar A. Circumstances attending 100 sudden deaths from coronary heart disease with coroner's necropsies. Br Heart J 1975; 37 (11): 1133-43
6. Bompadre S, Bedetta C, Capone P, et al. Pharmacokinetics and pharmacodynamics of amlodipine in comparison with nifedipine AR in patients with mild to moderate hypertension. Curr Ther Res 1991; 49 (5): 832-42
7. Helliott HL, Meredith PA. The clinical consequences of the absorption, distribution, metabolism and excretion of amlodipine. Postgrad Med J 1991; 67 Suppl. 3: S20-23
8. Hosie J, Bremner AD, Fell PJ, et al. Comparison of early side effects with amlodipine and nifedipine retard in hypertension. Cardiology 1992; 80 Suppl. 1: 54-9
9. Fisher M, Grotta J. New uses for calcium channel blockers - therapeutic implications. Drugs 1993; 46 (6): 961-75
10. Abernethy DR. The pharmacokinetic profile of amlodipine. Am Heart J 1989; 118 (5 Pt 2): 1100-3
11. Raftery EB, Heber ME, Brigden G, et al. 24-Hour blood pressure control with once daily calcium antagonist amlodipine. J Cardiovasc Pharmacol 1991; 17 Suppl. 1: S8-13
12. Cagli V, Germanò U. Ipertensione csscnziale lieve: è ragionevole un trattamento per le sole ore notturne. In: Prati PL, editor. Conoscere e curare il cuore 92. Ciba-Geigy Edizioni, 1992: 189
13. Safar ME. Vasodilatation, a key-point in hypertension. In: M. Safar, editor. Clinical research in essential hypertension. New York: Schattaner, 1989: 133
14. Frohlich ED. Cardiac hypertrophy in hypertension. N Engl J Med 1987; 317 (13): 831-3
15. White WB. Analysis of ambulatory blood pressure data in antihypertensive drug trials. J Hypertens 1991; 9 Suppl. 1: S27-32